Abstract
Background: Merkel cell carcinoma (MCC) is an aggressive cutaneous tumor with a propensity for local recurrence, regional and distant metastases. There are no well-defined prognostic factors that predict behavior of this tumor, nor are treatment guidelines well established.
Methods: Staging of patients with a new diagnosis of MCC was attempted using selective lymphadenectomy concurrent with primary excision. Preoperative and intraoperative mapping, excision, and thorough histologic evaluation of the first lymph node draining the tumor primary site [sentinel node] was performed. Patients with tumor metastasis in the sentinel node underwent complete resection of the remainder of the lymph node basin.
Results: Twelve patients underwent removal of 22 sentinel nodes. Two patients demonstrated metastatic disease in their sentinel lymph nodes, and complete dissection of the involved nodal basin revealed additional positive nodes. The node-negative patients received no further surgical therapy, with no evidence of recurrent local or regional disease at a maximum of 26 months follow-up (median 10.5 months).
Conclusions: While the data are preliminary and initial follow-up is limited, early results suggest that sentinel lymph node mapping and excision may be a useful adjunct in the treatment of MCC. This technique may identify a population of patients who would benefit from further surgical lymph node excision.
Similar content being viewed by others
References
Toker C. Trabecular carcinoma of the skin.Arch Dermatol 1972;105:107–10.
De Wolf-Peeters C, Marien K, Mebis J, Desmet V. A cutaneous APUDoma or Merkel cell tumor?Cancer 1980;46:1810–6.
Hitchcock CL, Bland KI, Laney RG, Franzini D, Harris B, Copeland E. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis and treatment.Ann Surg 1988;207:201–7.
Shaw JHF, Rumball E. Merkel cell tumor. Clinical behavior and treatment.Br J Surg 1991;78:138–42.
Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper W. Merkel cell carcinoma. Prognosis and management.Arch Surg 1991;126:1514–9.
Pilotti S, Rilke F, Bartoli C, Grisotti A. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma.J Clin Oncol 1988;6:1863–73.
Balch CM, Soong S-J, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage 1) melanoma treated in Alabama, USA, and New South Wales, Australia.Ann Surg 1982;196:677–85.
Smith D, Bielamowicz S, Kagan AR, Anderson PJ, Peddada AV. Cutaneous neuroendocrine (Merkell cell) carcinoma. A report of 35 cases.Am J Clin Oncol 1995;18:199–203.
Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma.Laryngoscope 1992;102:244–49.
Goepfert H, Remmler D, Silva E, Wheeler B. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck.Arch Otolaryngol 1984;110:707–12.
Marks ME, Kim Ry, Salter MM. Radiotherapy as an adjunct in the management of Merkel cell carcinoma.Cancer 1990;65:60–4.
Wilder R, Harari P, Grahan A, Shimm D, Cassady J. Merkel cell carcinoma: improved locoregional control with postoperative radiation therapy.Cancer 1991;68:1004–8.
Cotlar A, Gates J, Gibbs F. Merkel cell carcinoma: combined surgery and radiotherapy.Am Surg 1986;52:159–64.
Morton DL, Wen DR, Wong JH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.
Ross M, Reintgen DS, Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.Semin Surg Oncol 1993;9:219–23.
Reintgen DS, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastasis.Ann Surg 1994;220:759–67.
Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM. A rational approach to the surgical management of melanoma.Ann Surg 1977;186(4):481–90.
Norman J, Cruse W, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma.Am J Surg 1991;162:432–7.
Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell) carcinoma of the skin. A clinicopathologic study of 43 cases.Am J Surg Pathol 1985;9:95–108.
Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes.Surg Oncol 1993;2:137–43.
Tennvall J, Biorklund A, Johansson L, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients.Eur J Surg Oncol 1989;15:1–9.
Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen DS. Identification of lymphatic basins in patients with cutaenous melanoma.Semin Surg Oncol 1993;9:224–7.
Feun LG, Savaraj N, Legha SS, Silva EG, Benjamin RS, Burgess MA. Chemotherapy for metastatic Merkel cell carinoma. Review of the M.D. Anderson Hospital's experience. Cancer 1988;62:683–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Messina, J.L., Reintgen, D.S., Cruse, C.W. et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Annals of Surgical Oncology 4, 389–395 (1997). https://doi.org/10.1007/BF02305551
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02305551